Posted
July 24 - British drugmaker, GlaxoSmithKline, marred by bribery allegations in China, is announcing its second quarter results. Joanne Nicholson looks at whether the company will be able to offset damage to GSK’s reputation and help calm the waters for other pharmaceuticals being drawn into the affair
01:51
01:57
01:23
02:05
01:23
02:26
01:30
02:07
02:26
02:14
02:04
01:10
01:06
01:58
01:35
01:17
01:14
00:59
00:26
01:01
00:46
02:06
01:33
01:31
01:26
00:50
01:32
01:18
00:59
01:48
01:10
01:10
00:56
01:04
01:25
00:26
01:33
02:06
01:24
01:24
01:37
01:10
01:52
01:34
01:37
02:34
01:59
01:54
01:10
01:38
01:49
01:09
01:40
01:42
01:34
01:45
03:01
03:04
01:38
01:47
00:59
01:59
00:42
00:58
01:04
01:07
00:46
00:55
01:27
01:01
01:00
01:33
01:28
01:06
01:16
01:50
01:02